Aurora Cannabis Inc. (ACB)
USD 4.24
(-5.15%)
USD 4.24
(-5.15%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 47.57 Million CAD | 31.55% |
| 2022 | 36.16 Million CAD | -84.71% |
| 2021 | 236.48 Million CAD | -34.06% |
| 2020 | 358.61 Million CAD | -5.29% |
| 2019 | 378.62 Million CAD | -4.18% |
| 2018 | 395.15 Million CAD | 96.83% |
| 2017 | 200.76 Million CAD | 214.58% |
| 2016 | 63.81 Million CAD | 1337.63% |
| 2015 | 4.43 Million CAD | 93.68% |
| 2014 | 2.29 Million CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q3 | 47.57 Million CAD | -39.29% |
| 2023 FY | 47.57 Million CAD | 31.55% |
| 2023 Q1 | 79.96 Million CAD | -66.19% |
| 2023 Q2 | 78.36 Million CAD | -2.0% |
| 2022 Q4 | 236.48 Million CAD | 195.73% |
| 2022 Q3 | 79.96 Million CAD | -58.93% |
| 2022 Q2 | 194.7 Million CAD | -31.94% |
| 2022 FY | 36.16 Million CAD | -84.71% |
| 2022 Q1 | 286.06 Million CAD | 20.96% |
| 2021 Q1 | 363.24 Million CAD | 1.29% |
| 2021 Q2 | 369.85 Million CAD | 1.82% |
| 2021 Q3 | 343.55 Million CAD | -7.11% |
| 2021 Q4 | 236.48 Million CAD | -31.16% |
| 2021 FY | 236.48 Million CAD | -34.06% |
| 2020 Q4 | 358.61 Million CAD | -12.05% |
| 2020 Q3 | 407.72 Million CAD | -2.63% |
| 2020 Q2 | 418.75 Million CAD | 13.22% |
| 2020 Q1 | 369.85 Million CAD | -2.32% |
| 2020 FY | 358.61 Million CAD | -5.29% |
| 2019 Q2 | 544.43 Million CAD | 4.47% |
| 2019 Q1 | 521.13 Million CAD | 31.88% |
| 2019 FY | 378.62 Million CAD | -4.18% |
| 2019 Q3 | 539.05 Million CAD | -0.99% |
| 2019 Q4 | 378.62 Million CAD | -29.76% |
| 2018 Q3 | 418.34 Million CAD | 23.41% |
| 2018 FY | 395.15 Million CAD | 96.83% |
| 2018 Q4 | 395.15 Million CAD | -5.54% |
| 2018 Q2 | 338.99 Million CAD | 16.93% |
| 2018 Q1 | 289.9 Million CAD | 44.4% |
| 2017 Q3 | 206.61 Million CAD | 84577.46% |
| 2017 Q4 | 200.76 Million CAD | -2.83% |
| 2017 FY | 200.76 Million CAD | 214.58% |
| 2017 Q1 | 66.84 Million CAD | 4.74% |
| 2017 Q2 | 244 Thousand CAD | -99.63% |
| 2016 Q4 | 63.81 Million CAD | 240.87% |
| 2016 Q1 | 11.85 Million CAD | 167.09% |
| 2016 Q2 | 18.94 Million CAD | 59.75% |
| 2016 Q3 | 18.72 Million CAD | -1.16% |
| 2016 FY | 63.81 Million CAD | 1337.63% |
| 2015 FY | 4.43 Million CAD | 93.68% |
| 2015 Q3 | 4 Million CAD | 33.33% |
| 2015 Q1 | 3 Million CAD | 30.89% |
| 2015 Q2 | 3 Million CAD | 0.0% |
| 2015 Q4 | 4.43 Million CAD | 10.98% |
| 2014 Q4 | 2.29 Million CAD | 189.38% |
| 2014 FY | 2.29 Million CAD | 0.0% |
| 2014 Q1 | 745.76 Thousand CAD | 0.0% |
| 2014 Q3 | 792.04 Thousand CAD | 3.61% |
| 2014 Q2 | 764.46 Thousand CAD | 2.51% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Theratechnologies Inc. | 51.26 Million USD | 7.193% |
| Harrow Health, Inc. | 183.17 Million USD | 74.028% |
| Dynavax Technologies Corporation | 252.41 Million USD | 81.153% |
| Biofrontera Inc. | 804 Thousand USD | -5817.164% |
| Cronos Group Inc. | 1.55 Million USD | -2951.572% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -54582.759% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 90.453% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | -39.146% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -10355.824% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -272.133% |
| Radius Health, Inc. | 339.66 Million USD | 85.994% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| DURECT Corporation | 2.7 Million USD | -1660.696% |
| ProPhase Labs, Inc. | 10.25 Million USD | -363.775% |
| Safety Shot Inc | 304.9 Thousand USD | -15502.79% |
| Phibro Animal Health Corporation | 458.28 Million USD | 89.619% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -40516.756% |
| Alvotech | 1.02 Billion USD | 95.371% |
| Assertio Holdings, Inc. | 38.51 Million USD | -23.524% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -43.312% |
| Rockwell Medical, Inc. | 8.29 Million USD | -473.665% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -8725.772% |
| Procaps Group S.A. | 28.41 Million USD | -67.455% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | -257.001% |
| SCYNEXIS, Inc. | 12.15 Million USD | -291.266% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -337.382% |
| Viatris Inc. | 16.18 Billion USD | 99.706% |
| OptiNose, Inc. | 611 Thousand USD | -7686.252% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -14059.308% |
| Tilray Brands, Inc. | 287.93 Million USD | 83.478% |
| PetIQ, Inc. | 437.82 Million USD | 89.134% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -8725.772% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 81.582% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Alimera Sciences, Inc. | 64.48 Million USD | 26.229% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 90.29% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -35116.783% |
| Organogenesis Holdings Inc. | 60.74 Million USD | 21.682% |
| Journey Medical Corporation | 14.62 Million USD | -225.359% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -593.765% |
| Alpha Teknova, Inc. | 13.25 Million USD | -259.022% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -6507.5% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | 60.523% |
| PainReform Ltd. | 30 Thousand USD | -158480.0% |
| Cosmos Health Inc. | 3.03 Million USD | -1467.336% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | -45.22% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -628.322% |
| Embecta Corp. | 1.62 Billion USD | 97.073% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 90.741% |
| Incannex Healthcare Limited | 210 Thousand USD | -22554.286% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -211490.464% |
| Shineco, Inc. | 10.01 Million USD | -374.917% |
| Procaps Group, S.A. | 28.41 Million USD | -67.455% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 84.637% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | 47.765% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 92.278% |
| Alvotech | 1.02 Billion USD | 95.371% |
| Hempacco Co., Inc. | 5.93 Million USD | -702.124% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 15.373% |
| Bright Green Corporation | 201.78 Thousand USD | -23476.813% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 90.515% |
| Kamada Ltd. | 7.43 Million USD | -539.607% |
| Indivior PLC | 235.66 Million USD | 79.813% |
| Evoke Pharma, Inc. | 5 Million USD | -851.48% |
| Flora Growth Corp. | 942 Thousand USD | -4950.318% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -211490.464% |
| Evolus, Inc. | 120.35 Million USD | 60.473% |
| HUTCHMED (China) Limited | 48.18 Million USD | 1.276% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 91.926% |
| Akanda Corp. | 2.49 Million USD | -1805.128% |